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1. Introduction 
Measurement of the steady state concentrations of
intermediates of the pentose phosphate pathway have 
been made in conditions where marked changes are 
known to occur in the pattern of glucose metabolism 
and where it has been established that alterations oc- 
cur in both the oxidative and non-oxidative reactions 
of this pathway. The conditions chosen were alloxan- 
diabetes with and without insulin treatment, starvation 
and starvation followed by refeeding ahigh carbohy- 
drate diet or a high fat diet. In alloxan-diabetes, the 
most striking change was a marked increase in sedo- 
heptulose-7-phosphate. Changes in 6-phosphogluco- 
nate and pentose phosphate suggested an inhibition 
of 6-phosphogluconate d hydrogenase. Insulin treat- 
ment for 3 days partially reversed this latter effect but 
the sedoheptulose-7-phosphate concentration remained 
high. Starvation and starvation followed by refeeding a
high fat diet which decreases the flux of glucose through 
the pentose phosphate pathway, were found to cause 
a lowering of metabolite levels. Refeeding high carbo- 
hydrate diet restored the pentose phosphate l vel to 
control value, the sedoheptulose-7-phosphate remained 
low in this condition. These results uggest control 
points at both the oxidative reactions of the pentose 
phosphate cycle and at transketolase. 
2. Materials and methods 
The preparation of the enzymes and estimation of 
North-Holland Publishing Company - Amsterdam 
metabolites were as described previously [13. We are 
indebted to Dr. B. L. Horecker for the transaldolase 
used in these experiments. The metabolites were de- 
termined using the standard rapid freezing technique 
with liquid nitrogen [ 21. The metabolites were de- 
termined on perchloric acid extracts, neutralised and 
concentrated by freeze-drying; specific enzymic 
methods were used. 
Starvation and refeeding high carbohydrate and 
high fat diets: Adult male albino rats of 170-190 g 
group were used. The control group received ad li- 
bitum the standard laboratory rat diet 41 B contain- 
ing 65% carbohydrate, 16% protein and 3% fat, the 
remaining animals were starved for 72 hours and 
refed a high carbohydrate diet of white bread (83% 
carbohydrate, 14% protein, 3% fat) for 3 days or a 
high fat diet (6% fat, 1% carbohydrate, 30% protein 
and % cellulose filler) for 3 days before killing the 
rats for estimation of metabolites. 
Alloxan-diabetes and treatment with insulin: Adult 
male albino rats of 200 g body weight were used. Dia- 
betes was induced by subcutaneous injection of alloxan 
(20 mg/lOO g body weight) into rats previously starved 
for 48 hours. These rats were given 2 units of prota- 
mine zinc insulin/day for 5 days, this was then with- 
drawn and the alloxan-diabetic rats were kept for 3 
weeks on the stock diet. The blood sugar was in ex- 
cess of 400 mg/lOO ml blood. At the end of this 
period one group was used without further treatment 
and the other given subcutaneously 2 units of prota- 
mine zinc insulin daily for 3 days before killing the 
rats for estimation of metabolites. 
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3. Results and discussion 
The results of these experiments are summarized 
in table 1. In alloxan diabetic rats there was a tenden- 
cy for 6phosphogluconate o be increased coupled 
with a fall in the pentose phosphate concentration 
suggesting a relative decrease in 6-phosphogluconate 
dehydrogenase activity. This is reflected in the quo- 
tient 6-phosphogluconateipentose phosphate which 
more than doubles in the diabetic rats. At the same 
time there is also a fall in the quotient glucose&- 
phosphate/6-phosphogluconate i  the alloxan-dia- 
betic group to approximately one third of the control 
value. This is probably related to the more marked 
decrease in 6-phosphogluconate d hydrogenase than 
glucose+phosphate d hydrogenase in diabetic rat 
liver [3]. 
The most striking change in the alloxandiabetic 
rats is the increase in sedoheptulose-7-phosphate to 
almost wice the control value. This suggests control 
at transketolase but at present it is difficult to inter- 
pret this change since measurements have shown a 
decrease in transketolase to approximately 70% of 
control and an unchanged transaldolase in this con- 
dition [4,5], alterations which might be expected to 
lead to a fall in sedoheptulose-7-phosphate. Another 
factor known to be concerned in the control of sedo- 
heptulose-7-phosphate in liver and in ascites tumour 
cells is the concentration of glyceraldehyde-3-phos- 
phate [ 1,6] but no significant differences were found 
in the concentration of this metabolite in liver from 
alloxan-diabetic rats (table 1). 
Treatment of alloxan-diabetic rats with insulin for 
3 days did not greatly alter the metabolite pattern 
compared with the untreated group, however, the 
pentose phosphate concentration was somewhat in- 
creased and there was a small decrease in the 6-phos- 
phogluconateipentosephosphate quotient. Both sedo- 
heptulose-7-phosphate nd6phosphogluconate were 
increased above the normal control value. In this con- 
text, the three-fold increase in glucose&phosphate d - 
hydrogenase and two-fold increase in transketolase in 
alloxan-diabetic rats treated with insulin may be of im- 
portance [4]. 
Previous work using ( l-14C)glucose and (6-14C)glu- 
case and measuring the quotient of the incorporation 
of these sugars into 14C0,, while difficult to interpret 
quantitatively, did suggest that there was a relative in- 
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crease in the metabolism of glucose by way of the pen- 
tose phosphate pathway in both alloxandiabetic rats 
and alloxandiabetic rats treated with insulin [3] ; the 
present results are in keeping with this view. 
Starvation and starvation followed by refeeding a
high fat diet both resulted in decreased concentrations 
of key metabolites of the pentose phosphate pathway. 
Pentose phosphate and sedoheptulose-7-phosphate 
were both decreased after 72 hours starvation, again 
control at 6-phosphogluconate d hydrogenase is sug- 
gested by the increase in 6-phosphogluconate/pentose 
phosphate quotient which is increased by a factor of 
two. 
There is a very marked fall in 6-phosphogluconate 
in starved rats refed a high fat diet compared with the 
starved group, Examination of the activity of glucose- 
6-phosphate dehydrogenase and of 6-phosphogluconate 
dehydrogenase in the two groups hows that while the 
latter enzyme was not altered, the glucose-6-phosphate 
dehydrogenase was increased from 0.89 + 0.09 units 
in the starved animals to 1.46 + 0.08 in rats refed a 
high fat diet. Furthermore, the glucose&phosphate 
concentration of the two groups of rats was the same 
and although low, 50m pmoles/g liver, was neverthe- 
less still some ftiur-fold higher than the Km-G&P for 
this enzyme in liver which is 1.3X 10e5 M [7] . This 
suggests he possibility that glucose-6-phosphate dehy- 
drogenase is inhibited by a metabolite such as long 
chain acyl CoA to which this enzyme is known to be 
particularly sensitive [8]. A further possibility is con- 
trol by the concentration of NADP+ which may be- 
come more rate-limiting in a condition of fat oxida- 
tion as opposed to fat synthesis. 
Starvation followed by refeeding ahigh carbohy- 
drate diet raised the concentration of glucose-6-phos- 
phate and pentose phosphate but did not alter neither 
6-phosphogluconate nor sedoheptulose-7-phosphate. 
The control at 6phosphogluconate d hydrogenase is 
again shown by the fall in the quotient 6_phospho- 
gluconate/pentosephosphate which returned towards 
the control value. 
The present results indicate that in addition to 
control of the pentose phosphate pathway at the oxi- 
dative reactions there is also a complex control at the 
transketolase r action as indicated by the marked 
changes in sedoheptulose-7-phosphate in these differ- 
ent conditions. Kaufman, Brown, Passonneau and 
Lowry [9] from a study of metabolites of the pentose 
phosphate pathway in brain in conditions of increased 
and decreased glucose utilisation have concluded that 
control is exerted at 6-phosphogluconate d hydro- 
genase. The present results are in accord with this 
view. The higher Km of 6-phosphogluconate d hydro- 
genase for NADP+ compared with glucose&phosphate 
dehydrogenase may be of importance in this context 
[7]. Another factor which may play a part in the con- 
trol of 6-phosphogluconate d hydrogenase is the ratio 
6-phosphogluconate: fructose diphosphate. Carter and 
Parr [lo] have shown that fructose diphosphate isa 
competitive inhibitor of 6phosphogluconate d hydro- 
genase and that when present in equimolar amounts, 
a 25% inhibition was found. In most of the present 
conditions tudied the quotient 6-phosphogluconate/ 
fructose diphosphate was approximately two, but in 
the case of starved rats refed a high fat diet this quo- 
tient is less than one (fructose diphosphate concen- 
tration of 8m pmoles/g liver) and this may also be a 
contributory factor to the low pentose phosphate 
concentration i  liver in this condition. 
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